The FDA rejects a spine device from Medtronic (MDT -2.9%) amid outside concerns regarding...

|About: Medtronic plc (MDT)|By:, SA News Editor

The FDA rejects a spine device from Medtronic (MDT -2.9%) amid outside concerns regarding whether an ingredient used in the product might be linked to cancer. The rejection also raises questions about a separate Medtronic spine product, already on the market, that uses the same ingredient but which contributed $800M in sales last year.